Disease/Infection News

RSS

A step closer to a universal influenza virus vaccine

Researchers at Mount Sinai School of Medicine have developed a new influenza vaccine that brings science one step closer to a universal influenza vaccine that would eliminate the need for seasonal flu shots. The new findings can be found in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.

26 May 2010

Presidio Pharmaceuticals to advance PPI-1301 inhibitor from HCV NS5A program into clinical development

Presidio Pharmaceuticals, Inc. announced today that they have selected a second clinical candidate, PPI-1301, from their hepatitis C virus (HCV) NS5A program for advancement into clinical development. Presidio's first NS5A inhibitor, PPI-461, is currently undergoing evaluation in a Phase 1a clinical study.

26 May 2010

6-month results of NovoStent's SAMBA trial for atherosclerotic disease in SFA and popliteal arteries

NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.

26 May 2010

Antiviral treatment, SVR prevent esophageal varices in patients with HCV-induced cirrhosis

Italian researchers have discovered that antiviral treatment and sustained virologic response prevents esophageal varices in patients with compensated hepatitis C -induced cirrhosis, indicating that endoscopic surveillance can be safely delayed or avoided in these patients. Full findings are published in the June issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.

26 May 2010

AHF spearheads e-letter-writing campaign to stop de-funding of AIDS clinics in Antelope Valley

An online e-letter-writing campaign spearheaded by AIDS Healthcare Foundation (AHF) targeting Los Angeles County Supervisor Michael D. Antonovich (Fifth District) over the decision by LA County to de-fund two longstanding AIDS clinics in the Antelope Valley is heating up.

26 May 2010

UT Southwestern Medical Center researchers identify novel chemical compounds with anti-malarial activity

As part of a multicenter study, UT Southwestern Medical Center researchers have identified a series of chemical compounds that might serve as starting points for the identification of new classes of anti-malarial drugs.

26 May 2010

CEVEC, Pevion Biotech sign license option agreement for transient CAP-T cell expression technology

CEVEC Pharmaceuticals, the German developer of a novel human expression system derived from amniocytes, announced today the signing of an exclusive license option agreement with Pevion Biotech, the Swiss vaccine company. The agreement enables Pevion Biotech to exclusively use CEVEC's transient CAP-T™ cell expression technology to manufacture and commercialize a protein antigen for vaccination against a widespread human infectious disease.

26 May 2010

MedMira obtains NHS Supply Chain listing for Reveal Rapid HIV Test in the UK

MedMira Inc., a developer of rapid diagnostic technology and solutions, today announced that the Company's Reveal Rapid HIV Test is now one of three rapid HIV tests listed by the National Health Services Supply Chain in the United Kingdom, and the only one able to address both point of care and laboratory testing requirements.

26 May 2010

Researchers present more findings for microbicides, prep at M2010 conference

Researchers on Monday at the International Microbicides Conference in Pittsburgh continued to present data on HIV prevention research, Reuters reports. The news service outlines several prevention methods being researched, including an intravaginal ring that over time releases two antiretrovirals - dapivirine and maraviroc - for up to a month, and a vaginal tablet that time-releases the antiretrovirals dapivirine and DS003 for up to 12 hours.

26 May 2010

AHF urges Obama to address growing ADAP crisis

As many states across the nation face budget and funding shortfalls that are crippling their lifesaving AIDS Drug Assistance Programs (ADAPs), AIDS Healthcare Foundation (AHF), the largest global AIDS organization, is urging President Barack Obama to redirect a portion of unspent stimulus funds in the Health and Human Services Department in order to address the growing ADAP crisis.

26 May 2010

G7 aid delivers 'impressive results,' commitment falls short of 2005 pledge

According to an annual ONE report, which tracks progress on aid commitments made at the 2005 G8 summit in Gleneagles, Scotland, the G7 - Canada, France, Germany, Italy, Japan, the United Kingdom and the U.S. - is "on track to deliver 61 percent of their combined commitments to sub-Saharan Africa, or $13.7 billion of the $22.6 billion increase they promised," allAfrica.com reports.

26 May 2010

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Vertex Pharmaceuticals Incorporated today announced that 75% of people chronically infected with genotype 1 hepatitis C virus (HCV) who had not previously been treated achieved a sustained viral response (SVR or viral cure) after receiving a 12-week telaprevir-based combination regimen, followed by treatment with pegylated-interferon and ribavirin alone, in the Phase 3 ADVANCE trial.

26 May 2010

Experts warn increasing IDUs in eastern, southern Africa could threaten HIV/AIDS fight

An increase in the number of injection drug users (IDUs) in eastern and southern Africa stands to harm efforts to control the spread of HIV/AIDS in the region, warned experts gathered at the World Forum Against Drug conference in Sweden on Monday, Agence France-Presse reports.

26 May 2010

Osteopathic manipulative medicine reduces length of hospital stays for pneumonia patients: Research

Older patients battling pneumonia spent less time in the hospital when treated using osteopathic manipulative medicine - a drug-free form of hands-on medical care focusing on increasing muscle motion - in addition to conventional care, recently published research shows.

26 May 2010

Dangerous bacterium appears in Australia for the first time

Clostridium difficile is a bacterium that has killed thousands abroad. Now is has been detected in three Australians for the first time. The bacterium was detected in three patients at Melbourne's Epworth Hospital.

25 May 2010

Vical receives $4.0M grant to support development of novel vaccine for CMV infection

Vical Incorporated announced today that the company is collaborating with leading pediatric infectious disease researchers Stuart P. Adler, M.D., and Michael A. McVoy, Ph.D., of Virginia Commonwealth University under a five-year, approximately $4.0 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

25 May 2010

Influenza A(H1N1) appears milder than seasonal flu in tropical environment: Report

In a tropical environment, influenza A(H1N1) appeared milder than seasonal flu, was less likely to cause fever and upset stomach and more likely to infect younger individuals, according to a report in the May 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

25 May 2010

Family of EPA-registered disinfecting products to be launched

An innovative family of EPA-registered disinfecting products will be launched through a new direct selling company, it was announced today.

25 May 2010

New research finding may change direction of vaccine research for M. tuberculosis

Scientists at NYU Langone Medical Center have discovered that the strategy of "immune evasion" common to many viruses, bacteria and parasites, is uncommon to M. tuberculosis where the antigens remain strikingly unchanged and homogenous. The study published in Nature Genetics on May 23, 2010, suggests that M. tuberculosis antigens do not mutate because they hope to be recognized by the body's immune system- perhaps because the host immune mechanism that leads to the typical lung destruction and cough can contribute to the spread of the disease.

25 May 2010

Biomagnetics Diagnostics presents new series of videos on world's first handheld Integrated Optical Biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the availability of a new series of video taped interviews of CEO, Clayton Hardman where he presents the world's first handheld Integrated Optical Biosensor (IOBS), which was recently licensed under an agreement with Los Alamos National Security LLC.

25 May 2010

Disease/Infection News

A step closer to a universal influenza virus vaccine

Presidio Pharmaceuticals to advance PPI-1301 inhibitor from HCV NS5A program into clinical development

6-month results of NovoStent's SAMBA trial for atherosclerotic disease in SFA and popliteal arteries

Antiviral treatment, SVR prevent esophageal varices in patients with HCV-induced cirrhosis

AHF spearheads e-letter-writing campaign to stop de-funding of AIDS clinics in Antelope Valley

UT Southwestern Medical Center researchers identify novel chemical compounds with anti-malarial activity

CEVEC, Pevion Biotech sign license option agreement for transient CAP-T cell expression technology

MedMira obtains NHS Supply Chain listing for Reveal Rapid HIV Test in the UK

Researchers present more findings for microbicides, prep at M2010 conference

AHF urges Obama to address growing ADAP crisis

G7 aid delivers 'impressive results,' commitment falls short of 2005 pledge

Vertex reports 75% patients with HCV achieve viral cure with 12-week telaprevir-based combination regimen

Experts warn increasing IDUs in eastern, southern Africa could threaten HIV/AIDS fight

Osteopathic manipulative medicine reduces length of hospital stays for pneumonia patients: Research

Dangerous bacterium appears in Australia for the first time

Vical receives $4.0M grant to support development of novel vaccine for CMV infection

Influenza A(H1N1) appears milder than seasonal flu in tropical environment: Report

Family of EPA-registered disinfecting products to be launched

New research finding may change direction of vaccine research for M. tuberculosis

Biomagnetics Diagnostics presents new series of videos on world's first handheld Integrated Optical Biosensor

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News